Windtree Therapeutics Delays Quarterly Financial Report Filing
Windtree Therapeutics Inc. has delayed the filing of its Quarterly Report on Form 10-Q for the period ended September 30, 2025, citing the need for additional time to finalize financial statements and disclosures. The company expects to file the report within five calendar days of the original due date.
Windtree Therapeutics Inc. has announced a delay in filing its Quarterly Report on Form 10-Q for the period ended September 30, 2025. The company cited the need for additional time to finalize its financial statements and related disclosures, and expects to file the report within five calendar days of the original due date. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Windtree Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-035192), on November 14, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
